367 matches for your search in the start-up spotlight
rss
Founded in January 2024, Toleris Biotherapeutics is a pioneering biotech company based in Würzburg, Germany. Led by an experienced team of scientists and entrepreneurs, we specialize in developing first-in-class AutoImmunity Modifying Biologics (AIM Bios) - a breakthrough therapeutic approach ...
Synendos Therapeutics AG is a biopharmaceutical company founded in April 2019 as a spin-off of the University of Bern. Synendos develops an innovative therapeutic approach based upon first-in-class inhibitors (small molecules) that modulate a new drug target (not yet published). The inhibitors ...
Augustine Therapeutics is a biotechnology company focused on the treatment of neuromuscular, neurodegenerative and cardio-metabolic diseases through its next-generation approach to selectively inhibit HDAC6. Augustine’s HDAC6 inhibitors have been purposefully designed to selectively inhibit HDAC6 ...
Meliodays Medical GmbH, is a young pharmaceutical company focusing on the development of a new therapy for the hormone-free and locally acting treatment of menstrual pain. With MelioOne, Meliodays Medical is developing the first hormone-free, local solution to treat menstrual pain without ...
RNhale was founded in 2023 as a spinoff from the highly decorated pharmaceutical technology chair at Ludwig-Maximilians-Universität in Munich. Our origins are deeply embedded in the pharmaceutical industry, emphasizing regulatory knowledge and market access, with a particular focus on the ...
Cambridge-based TRIMTECH Therapeutic’s mission is to create novel small molecule degraders of protein aggregates that will combat neurodegenerative and inflammatory diseases including Alzheimer’s disease, a leading cause of death globally. The Company’s proprietary degrader technology is focused ...
Headquartered in Seattle and Singapore, Callio Therapeutics is focused on realizing the promise of multi-payload antibody-drug conjugates to transform cancer patient outcomes. The company is developing next-generation, multi-payload antibody-drug conjugates (ADCs) that feature differentiated ...
NEOGAP Therapeutics AB is a privately held clinical stage biopharmaceutical company with the main focus on immuno-oncology. The company was founded in 2016 by Dr. Hans Grönlund. We are located at Cancer Center Karolinska at Karolinska University Hospital, Solna, Sweden. Our vision is to ...
Citryll has translated a deep understanding of the neutrophil extracellular trap (NET) pathway to therapeutically address its central role in a broad range of inflammatory diseases. With a unique dual mode of action, the company’s lead antibody, CIT-013, has reached the clinic by demonstrating a ...
Noema Pharma is a clinical-stage biotech company advancing a portfolio of transformative therapeutics utilizing first-in-disease approaches targeting neuroscience-based conditions with high unmet need. Noema has four programs currently in active Phase 2 clinical trials evaluating pain in ...
